Skye Bioscience, Inc. Cash
Skye Bioscience, Inc. (SKYE) had Cash of $83.34 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2024-05-10
- 2024-03-31: Cash $83.34M.
- 2023-12-31: Cash $1.26M.
- 2023-09-30: Cash $5.13M.
- 2023-06-30: Cash $553.44K.
| Period end | Cash |
|---|---|
| 2024-03-31 | $83.34M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.26M 10-K · filed 2024-03-22 |
| 2023-09-30 | $5.13M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $553.44K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $1.24M 10-K · filed 2024-03-22 |
| 2022-09-30 | $415.39K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $2.93M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $6.01M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $8.98M 10-K · filed 2023-03-31 |
| 2020-12-31 | $2.47M 10-K · filed 2022-03-28 |
| 2020-03-31 | $667.00K 10-K · filed 2020-03-23 |
| 2019-12-31 | $1.83M 10-K · filed 2021-03-02 |
| 2018-12-31 | $1.85M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |